46 related articles for article (PubMed ID: 38726285)
1. Roles of RNA m
Cui W; Luo C; Zhou L; Yu T; Meng Y; Yu Q; Lei Z; Wang Y; Peng L; Luo Q; Tang D; Sun R; Yu L
Am J Cancer Res; 2024; 14(4):1768-1783. PubMed ID: 38726285
[TBL] [Abstract][Full Text] [Related]
2. RNA m5C methylation orchestrates BLCA progression via macrophage reprogramming.
Yan D; Xie Y; Huang L; Zhang Y; Gu R; Xie H; Huang X; Luo H
J Cell Mol Med; 2023 Aug; 27(16):2398-2411. PubMed ID: 37408139
[TBL] [Abstract][Full Text] [Related]
3. NOP2-mediated m5C Modification of c-Myc in an EIF3A-Dependent Manner to Reprogram Glucose Metabolism and Promote Hepatocellular Carcinoma Progression.
Zhang H; Zhai X; Liu Y; Xia Z; Xia T; Du G; Zhou H; Franziska Strohmer D; Bazhin AV; Li Z; Wang X; Jin B; Guo D
Research (Wash D C); 2023; 6():0184. PubMed ID: 37398932
[TBL] [Abstract][Full Text] [Related]
4. ALYREF mediates RNA m
Xue C; Gu X; Zheng Q; Shi Q; Yuan X; Su Y; Jia J; Jiang J; Lu J; Li L
Signal Transduct Target Ther; 2023 Mar; 8(1):130. PubMed ID: 36934090
[No Abstract] [Full Text] [Related]
5. Treg-selective IL-2 starvation synergizes with CD40 activation to sustain durable responses in lymphoma models.
Stirm K; Leary P; Wüst D; Stark D; Joller N; Karakus U; Boyman O; Tzankov A; Müller A
J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36822670
[TBL] [Abstract][Full Text] [Related]
6. Genetic variants in m5C modification core genes are associated with the risk of Chinese pediatric acute lymphoblastic leukemia: A five-center case-control study.
Wang X; Deng D; Yan Y; Cai M; Liu X; Luo A; Liu S; Zhang X; Jiang H; Liu X
Front Oncol; 2022; 12():1082525. PubMed ID: 36698387
[TBL] [Abstract][Full Text] [Related]
7. Active DNA demethylation promotes cell fate specification and the DNA damage response.
Wang D; Wu W; Callen E; Pavani R; Zolnerowich N; Kodali S; Zong D; Wong N; Noriega S; Nathan WJ; Matos-Rodrigues G; Chari R; Kruhlak MJ; Livak F; Ward M; Caldecott K; Di Stefano B; Nussenzweig A
Science; 2022 Dec; 378(6623):983-989. PubMed ID: 36454826
[TBL] [Abstract][Full Text] [Related]
8. Molecular determinants of clinical outcomes in a real-world diffuse large B-cell lymphoma population.
Alduaij W; Collinge B; Ben-Neriah S; Jiang A; Hilton LK; Boyle M; Meissner B; Chong L; Miyata-Takata T; Slack GW; Farinha P; Craig JW; Lytle A; Savage KJ; Villa D; Gerrie AS; Freeman CL; Gascoyne RD; Connors JM; Morin RD; Sehn LH; Mungall AJ; Steidl C; Scott DW
Blood; 2023 May; 141(20):2493-2507. PubMed ID: 36302166
[TBL] [Abstract][Full Text] [Related]
9. The 5-Hydroxymethylcytosine Landscape of Prostate Cancer.
Sjöström M; Zhao SG; Levy S; Zhang M; Ning Y; Shrestha R; Lundberg A; Herberts C; Foye A; Aggarwal R; Hua JT; Li H; Bergamaschi A; Maurice-Dror C; Maheshwari A; Chen S; Ng SWS; Ye W; Petricca J; Fraser M; Chesner L; Perry MD; Moreno-Rodriguez T; Chen WS; Alumkal JJ; Chou J; Morgans AK; Beer TM; Thomas GV; Gleave M; Lloyd P; Phillips T; McCarthy E; Haffner MC; Zoubeidi A; Annala M; Reiter RE; Rettig MB; Witte ON; Fong L; Bose R; Huang FW; Luo J; Bjartell A; Lang JM; Mahajan NP; Lara PN; Evans CP; Tran PT; Posadas EM; He C; Cui XL; Huang J; Zwart W; Gilbert LA; Maher CA; Boutros PC; Chi KN; Ashworth A; Small EJ; He HH; Wyatt AW; Quigley DA; Feng FY
Cancer Res; 2022 Nov; 82(21):3888-3902. PubMed ID: 36251389
[TBL] [Abstract][Full Text] [Related]
10. RNA modifications: importance in immune cell biology and related diseases.
Cui L; Ma R; Cai J; Guo C; Chen Z; Yao L; Wang Y; Fan R; Wang X; Shi Y
Signal Transduct Target Ther; 2022 Sep; 7(1):334. PubMed ID: 36138023
[TBL] [Abstract][Full Text] [Related]
11. Treatment strategies for patients with diffuse large B-cell lymphoma.
Poletto S; Novo M; Paruzzo L; Frascione PMM; Vitolo U
Cancer Treat Rev; 2022 Nov; 110():102443. PubMed ID: 35933930
[TBL] [Abstract][Full Text] [Related]
12. Role of main RNA modifications in cancer: N
Xue C; Chu Q; Zheng Q; Jiang S; Bao Z; Su Y; Lu J; Li L
Signal Transduct Target Ther; 2022 Apr; 7(1):142. PubMed ID: 35484099
[TBL] [Abstract][Full Text] [Related]
13. Biological roles of RNA m
Song H; Zhang J; Liu B; Xu J; Cai B; Yang H; Straube J; Yu X; Ma T
Biomark Res; 2022 Apr; 10(1):15. PubMed ID: 35365216
[TBL] [Abstract][Full Text] [Related]
14. Ten-eleven translocation-2 inactivation restrains IL-10-producing regulatory B cells to enable antitumor immunity in hepatocellular carcinoma.
Lu Z; Liu R; Wang Y; Jiao M; Li Z; Wang Z; Huang C; Shi G; Ke A; Wang L; Fu Y; Xia J; Wen H; Zhou J; Wang X; Ye D; Fan J; Chu Y; Cai J
Hepatology; 2023 Mar; 77(3):745-759. PubMed ID: 35243663
[TBL] [Abstract][Full Text] [Related]
15. Sox2 induces glioblastoma cell stemness and tumor propagation by repressing TET2 and deregulating 5hmC and 5mC DNA modifications.
Lopez-Bertoni H; Johnson A; Rui Y; Lal B; Sall S; Malloy M; Coulter JB; Lugo-Fagundo M; Shudir S; Khela H; Caputo C; Green JJ; Laterra J
Signal Transduct Target Ther; 2022 Feb; 7(1):37. PubMed ID: 35136034
[TBL] [Abstract][Full Text] [Related]
16. TET deficiency perturbs mature B cell homeostasis and promotes oncogenesis associated with accumulation of G-quadruplex and R-loop structures.
Shukla V; Samaniego-Castruita D; Dong Z; González-Avalos E; Yan Q; Sarma K; Rao A
Nat Immunol; 2022 Jan; 23(1):99-108. PubMed ID: 34937926
[TBL] [Abstract][Full Text] [Related]
17. Loss of 5-hydroxymethylcytosine expression is near-universal in B-cell lymphomas with variable mutations in epigenetic regulators.
Tanager KS; Yu J; Chiu BC; Carll TC; Tatarian AH; Riedell P; Smith S; Kline J; Venkataraman G
Haematologica; 2022 Apr; 107(4):966-969. PubMed ID: 34911281
[No Abstract] [Full Text] [Related]
18. Clinical Impact of Immune Cells and Their Spatial Interactions in Diffuse Large B-Cell Lymphoma Microenvironment.
Autio M; Leivonen SK; Brück O; Karjalainen-Lindsberg ML; Pellinen T; Leppä S
Clin Cancer Res; 2022 Feb; 28(4):781-792. PubMed ID: 34907083
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
